Daily snuff use during pregnancy, gestational length and birth weight; register-based study.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
04 Oct 2024
Historique:
received: 08 02 2024
accepted: 25 09 2024
medline: 5 10 2024
pubmed: 5 10 2024
entrez: 4 10 2024
Statut: epublish

Résumé

Snuff is a smokeless source of nicotine that is common in Scandinavia and increasingly used by women of fertile age. Persistent use of snuff during pregnancy has been associated with adverse pregnancy outcomes. Emerging data from the Medical Birth Registry of Norway distinguishes between occasional use and daily use. We provide preliminary estimates of associations between frequency of snuff and gestational length and birth weight. Data on snuff use during pregnancies delivered in 2020 and 2021 were available for the west and central regions of Norway. Associations of snuff use with gestational length and birth weight at term (39-41 weeks) were estimated using quantile regression at the 25th, the 50th and the 75th percentiles, with adjustments for mother's age, pre-pregnancy weight, and parity. We compared associations with the pregnancy outcomes according to maternal snuff and cigarette use. 12.4% of 18 042 non-smoking women reported daily use of snuff before pregnancy, and 4.6% reported continuing use during pregnancy, with 1.2% still reporting daily use in the last trimester. Women with daily use through the last trimester delivered babies with a median gestational length reduced by 3.4 days (95% CI: -5.0 to -1.7 days) compared with women who never used snuff. The reduction was even stronger at the 25th percentile of gestational age. The median term birth weight was reduced by 44 g (95% CI: -134 to 46 g). These associations were much weaker for women who quit snuff at some point during pregnancy or used snuff only occasionally. Mothers who smoked daily through the last trimester had a median gestational length reduced by 2.1 days (95% CI: -2.7 to -1.4) and a median term birth weight reduced by 294 g (95% CI: -325 to -262) compared with never-smokers. Daily snuff use through the last trimester reduced the median gestational length by more than three days. Snuff reduced birth weight, but not as much as smoking, suggesting that the predominant effect of smoking on fetal growth is not through nicotine but through the additional toxic chemicals in cigarettes or by reduced oxygen supply to the fetus.

Sections du résumé

BACKGROUND BACKGROUND
Snuff is a smokeless source of nicotine that is common in Scandinavia and increasingly used by women of fertile age. Persistent use of snuff during pregnancy has been associated with adverse pregnancy outcomes. Emerging data from the Medical Birth Registry of Norway distinguishes between occasional use and daily use. We provide preliminary estimates of associations between frequency of snuff and gestational length and birth weight.
METHODS METHODS
Data on snuff use during pregnancies delivered in 2020 and 2021 were available for the west and central regions of Norway. Associations of snuff use with gestational length and birth weight at term (39-41 weeks) were estimated using quantile regression at the 25th, the 50th and the 75th percentiles, with adjustments for mother's age, pre-pregnancy weight, and parity. We compared associations with the pregnancy outcomes according to maternal snuff and cigarette use.
RESULTS RESULTS
12.4% of 18 042 non-smoking women reported daily use of snuff before pregnancy, and 4.6% reported continuing use during pregnancy, with 1.2% still reporting daily use in the last trimester. Women with daily use through the last trimester delivered babies with a median gestational length reduced by 3.4 days (95% CI: -5.0 to -1.7 days) compared with women who never used snuff. The reduction was even stronger at the 25th percentile of gestational age. The median term birth weight was reduced by 44 g (95% CI: -134 to 46 g). These associations were much weaker for women who quit snuff at some point during pregnancy or used snuff only occasionally. Mothers who smoked daily through the last trimester had a median gestational length reduced by 2.1 days (95% CI: -2.7 to -1.4) and a median term birth weight reduced by 294 g (95% CI: -325 to -262) compared with never-smokers.
CONCLUSIONS CONCLUSIONS
Daily snuff use through the last trimester reduced the median gestational length by more than three days. Snuff reduced birth weight, but not as much as smoking, suggesting that the predominant effect of smoking on fetal growth is not through nicotine but through the additional toxic chemicals in cigarettes or by reduced oxygen supply to the fetus.

Identifiants

pubmed: 39367311
doi: 10.1186/s12884-024-06863-8
pii: 10.1186/s12884-024-06863-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

646

Informations de copyright

© 2024. The Author(s).

Références

International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol. 38. Tobacco Smoking. Switzerland: International Agency for Research on Cancer; 1986.
NIDA. 2021, April 12. What are the risks of smoking during pregnancy? Retrieved from https://nida.nih.gov/publications/research-reports/tobacco-nicotine-e-cigarettes/what-are-risks-smoking-during-pregnancy on 2023, August 16
McGrath-Morrow SA, Gorzkowski J, Groner JA, Rule AM, Wilson K, Tanski SE, Collaco JM, Klein JD. The Effects of Nicotine on Development. Pediatrics. 2020;145(3): e20191346. https://doi.org/10.1542/peds.2019-1346 .
doi: 10.1542/peds.2019-1346 pubmed: 32047098
Bonello K, Figoni H, Blanchard E, Vignier N, Avenin G, Melchior M, Cadwallader JS, Chastang J, Ibanez G. Prevalence of smoking during pregnancy and associated social inequalities in developed countries over the 1995–2020 period: A systematic review. Paediatr Perinat Epidemiol. 2023A;37(6):555–65. https://doi.org/10.1111/ppe.12989 .
doi: 10.1111/ppe.12989 pubmed: 37427978
https://www.ssb.no/helse/helseforhold-og-levevaner/statistikk/royk-alkohol-og-andre-rusmidler/artikler/flere-unge-snuser-i-norge-enn-i-sverige
Rutqvist LE, Curvall M, Hassler T, Ringberger T, Wahlberg I. Swedish snus and the GothiaTek® standard. Harm Reduct J. 2011;16(8):11. https://doi.org/10.1186/1477-7517-8-11 .
doi: 10.1186/1477-7517-8-11
Gartner CE, Hall WD, Vos T, Bertram MY, Wallace AL, Lim SS. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet. 2007;369:2010–4.
doi: 10.1016/S0140-6736(07)60677-1 pubmed: 17498798
Russell MA, Jarvis MJ, Devitt G, Feyerabend C. Nicotine intake by snuff users. Br Med J (Clin Res Ed). 1981;283(6295):814–7. https://doi.org/10.1136/bmj.283.6295.814 .
doi: 10.1136/bmj.283.6295.814 pubmed: 6794710
Brinchmann BC, Vist GE, Becher R, Grimsrud TK, Elvsaas IØ, Underland V, Holme JA, Carlsen KCL, Kreyberg I, Nordhagen LS, Bains KES, Carlsen KH, Alexander J, Valen H. Use of Swedish smokeless tobacco during pregnancy: A systematic review of pregnancy and early life health risk. Addiction. 2023M;118(5):789–803. https://doi.org/10.1111/add.16114 .
doi: 10.1111/add.16114 pubmed: 36524899
Cnattingius S, Källén K, Sandström A, Rydberg H, Månsson H, Stephansson O, Frisell T, Ludvigsson JF. The Swedish medical birth register during five decades: documentation of the content and quality of the register. Eur J Epidemiol. 2023;38(1):109–20. https://doi.org/10.1007/s10654-022-00947-5 .
doi: 10.1007/s10654-022-00947-5 pubmed: 36595114 pmcid: 9867659
Irgens LM. The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand. 2000;79(6):435–9 PMID: 10857866.
doi: 10.1034/j.1600-0412.2000.079006435.x pubmed: 10857866
https://www.fhi.no/nyheter/2023/flere-unge-menn-royker-av-og-til/
Dahlin S, Gunnerbeck A, Wikström AK, Cnattingius S, Edstedt Bonamy AK. Maternal tobacco use and extremely premature birth - a population-based cohort study. BJOG. 2016Nov;123(12):1938–46. https://doi.org/10.1111/1471-0528.14213 .
doi: 10.1111/1471-0528.14213 pubmed: 27411948
Rygh E, Gallefoss F, Grøtvedt L. Trends in maternal use of snus and smoking tobacco in pregnancy. A register study in southern Norway. BMC Pregnancy Childbirth. 2019;19(1):500. https://doi.org/10.1186/s12884-019-2624-9 .
doi: 10.1186/s12884-019-2624-9 pubmed: 31842873 pmcid: 6915947
Kreyberg I, Hilde K, Bains KES, Carlsen KH, Granum B, Haugen G, Hedlin G, Jonassen CM, Nordhagen LS, Nordlund B, Rueegg CS, Sjøborg KD, Skjerven HO, Staff AC, Vettukattil R, Lødrup Carlsen KC, PreventADALL Study Group. Snus in pregnancy and infant birth size: a mother-child birth cohort study. ERJ Open Res. 2019;5(4):00255–2019. https://doi.org/10.1183/23120541.00255-2019 .
doi: 10.1183/23120541.00255-2019 pubmed: 31803771 pmcid: 6885591

Auteurs

Rolv T Lie (RT)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. rolv.lie@uib.no.
Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway. rolv.lie@uib.no.

Maria C Magnus (MC)

Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

Håkon K Gjessing (HK)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

Allen J Wilcox (AJ)

Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.
Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, NC, USA.

Siri E Håberg (SE)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH